Lv5
1160 积分 2025-07-12 加入
Sodium butyrate ameliorates liver fibrosis in metabolic dysfunction-associated steatohepatitis rats via miR-155-5p/SOCS1/PDGF signaling pathway
7个月前
已完结
Eucommia alleviates high fat diet-induced MASLD via the F. prausnitzii/butyrate/GPR43/GLP-1 signaling
7个月前
已完结
Electroacupuncture at Zusanli Alleviates Sepsis by Regulating the TLR4-MyD88-NF-Kappa B Pathway and Diversity of Intestinal Flora
10个月前
已完结
Association Between Nonalcoholic Fatty Liver Disease and Risk of Early-onset Colorectal Cancer
10个月前
已完结
Is It Just About How Much You Drink? The Overlooked Role of Drinking Patterns in Fatty Liver Disease
10个月前
已关闭
451: LEAN STEATOTIC LIVER DISEASE (SLD) IN PREGNANT INDIVIDUALS: RESULTS FROM THE PROSPECTIVE FATTY LIVER IN PREGNANCY (FLIP) PROTOCOL
10个月前
已关闭
Sa1607: EFFECTS OF ANTIHYPERTENSIVE DIET (DASH DIET) ON LIVER ENZYMES AND LIPID PROFILE OF OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
10个月前
已完结
Sa1616: TO ASSESS METABOLIC SYNDROME SEVERITY SCORE IN METABOLIC DYSFUNCTION ASSOSCIATED FATTY LIVER DISEASE IN INDIAN POPULATION
10个月前
已关闭
Sa1613: LIVER AND CARDIOVASCULAR RISK ASSESSMENT USING THE NONALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
10个月前
已关闭
Sa1638: DIAGNOSTIC UTILITY OF A NEW NON-INVASIVE METHOD (HEPAMET) OF LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
10个月前
已关闭
皖公网安备34019202002308
